Benitez Barrios Sosimo Isaac

Benitez Barrios Sosimo Isaac

Auto-generated profile, based on publicly available information

Benitez Barrios Sosimo Isaac

Facultad de Química-Universidad Autónoma de Querétaro

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
BIBenitez Barrios Sosimo Isaac
Benitez Barrios Sosimo Isaac
GVGerardo Amaya Villagran
Gerardo Amaya Villagran
NANemesis Alhelí Pineda Alfaro
Nemesis Alhelí Pineda Alfaro
GÁGuithel Birmaher Ávalos
Guithel Birmaher Ávalos
ANAlexa Fernanda Uriostegui Navarro
Alexa Fernanda Uriostegui Navarro
CRCesar Martín Gónzalez Rico
Cesar Martín Gónzalez Rico
Immune senescence has emerged as one of the principal biological mechanisms linking aging with the development and progression of autoimmune rheumatic diseases. Rather than representing a simple decline in immune function, aging induces profound remodeling of both innate and adaptive immunity, characterized by chronic low-grade inflammation, loss of immune tolerance, impaired cellular regeneration, mitochondrial dysfunction, telomere shortening, epigenetic alterations, and expansion of senescent immune-cell populations. The objective of this review was to analyze current evidence regarding the mechanisms through which immune senescence reshapes autoimmune rheumatic diseases and to examine its clinical implications, biomarkers, and emerging therapeutic strategies. A narrative literature review was conducted using the scientific method and included publications retrieved from PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, SpringerLink, Nature, Frontiers, and Wiley. The evidence consistently demonstrated that inflammaging, adaptive immune remodeling, and cellular senescence contribute to disease progression, increased susceptibility to infections, reduced vaccine responsiveness, cardiovascular complications, frailty, osteoporosis, sarcopenia, and diminished functional capacity. Conventional inflammatory biomarkers remain widely used; however, increasing attention has been directed toward multi-omics technologies, epigenetic clocks, mitochondrial biomarkers, proteomics, metabolomics, and immune-cell phenotyping for more accurate assessment of biological immune aging. Current therapeutic approaches continue to rely on disease-modifying antirheumatic drugs and biologic agents, while emerging interventions—including JAK inhibitors, mTOR modulation, senolytic therapies, microbiome-targeted strategies, and precision medicine—offer promising opportunities for future individualized management. Overall, immune senescence should be recognized as a fundamental component of autoimmune rheumatic diseases, providing important opportunities for improving diagnosis, risk stratification, therapeutic decision-making, and long-term clinical outcomes in aging populations.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
YTYurany Duarte Torres
Yurany Duarte Torres
GVGerardo Amaya Villagran
Gerardo Amaya Villagran
AVAnthony Jesús Pastrana Villares
Anthony Jesús Pastrana Villares
BIBenitez Barrios Sosimo Isaac
Benitez Barrios Sosimo Isaac
MCMiguel Castellanos Contreras
Miguel Castellanos Contreras
DGDaniel Alberto Madrid González
Daniel Alberto Madrid González
Clonal hematopoiesis has emerged as a major biological process associated with aging and is increasingly recognized as a common mechanistic link between cardiovascular disease and hematologic malignancies. Advances in genomic sequencing have demonstrated that somatic mutations affecting hematopoietic stem cells, particularly in genes involved in epigenetic regulation and DNA repair, promote progressive clonal expansion and persistent inflammatory activation. This review integrates current international evidence regarding the molecular basis, epidemiology, pathophysiological mechanisms, cardiovascular associations, hematologic implications, diagnostic strategies, and emerging therapeutic perspectives of Clonal Hematopoiesis of Indeterminate Potential (CHIP). The available literature consistently indicates that mutations involving DNMT3A, TET2, ASXL1, JAK2, TP53, and PPM1D contribute to chronic immune dysregulation, endothelial dysfunction, accelerated atherosclerosis, and increased susceptibility to myeloid neoplasms. Although most individuals with CHIP remain clinically stable, factors such as larger clone size, multiple driver mutations, persistent cytopenias, and previous exposure to cytotoxic therapy are associated with less favorable outcomes. The evidence also highlights the growing role of next-generation sequencing and precision medicine in identifying individuals at increased cardiovascular and hematologic risk. Despite substantial progress, important challenges remain regarding standardized screening strategies, clinical surveillance, and implementation of mutation-guided management. Continued international collaboration, including broader participation from Latin American research groups, will be essential for improving understanding of clonal hematopoiesis and facilitating the translation of genomic discoveries into personalized clinical practice.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
CLCristobal Washigton Franco Lucas
Cristobal Washigton Franco Lucas
GVGerardo Amaya Villagran
Gerardo Amaya Villagran
JAJhon Alexander Ponce Alencastro
Jhon Alexander Ponce Alencastro
AVAnthony Jesús Pastrana Villares
Anthony Jesús Pastrana Villares
AOAndres Sebastián Freire Ortega
Andres Sebastián Freire Ortega
AOAshley Denisse Ayala Ochoa
Ashley Denisse Ayala Ochoa
Chronic kidney disease (CKD) without diabetes mellitus has become an increasingly recognized clinical entity whose progression cannot be explained exclusively by traditional hemodynamic mechanisms. Growing evidence indicates that endocrine dysregulation, metabolic remodeling, mitochondrial dysfunction, chronic inflammation, oxidative stress, and altered communication between the kidney and other organ systems play fundamental roles throughout disease development and progression. The present review critically analyzes current scientific evidence regarding the endocrine and metabolic mechanisms involved in non-diabetic CKD, integrating findings from nephrology, endocrinology, and internal medicine while incorporating information relevant to Latin American populations. A narrative review based on the Scientific Method was conducted using high-quality publications retrieved from internationally recognized databases and clinical practice guidelines. The available evidence demonstrates that persistent activation of the renin–angiotensin–aldosterone system, disruption of the fibroblast growth factor 23–Klotho axis, impaired vitamin D metabolism, insulin resistance, obesity-related endocrine alterations, mitochondrial dysfunction, and gut–kidney interactions contribute substantially to renal fibrosis, progressive loss of kidney function, and cardiovascular complications. Contemporary therapeutic approaches, particularly sodium–glucose cotransporter-2 inhibitors, have significantly modified disease management by providing nephroprotective effects beyond glycemic control. Emerging biomarkers and precision medicine strategies also show considerable potential for improving early diagnosis, individualized risk assessment, and targeted therapeutic interventions. Nevertheless, additional multicenter studies, particularly involving underrepresented regions such as Latin America, remain necessary to strengthen the current evidence base. Overall, non-diabetic CKD should be regarded as a complex multisystem disorder requiring an integrated clinical approach that combines endocrine, metabolic, cardiovascular, and nephrological perspectives to optimize patient outcomes.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
PVPatricia Equilea Veizaga
Patricia Equilea Veizaga
LSLuis A. Jacobo Saucedo
Luis A. Jacobo Saucedo
LPLic. Ernesto Marin Peña
Lic. Ernesto Marin Peña
LULic. Dina Berenissee Alvarez Ugarte
Lic. Dina Berenissee Alvarez Ugarte
MQMiguel Horacio Quijano
Miguel Horacio Quijano
ANAlexa Fernanda Uriostegui Navarro
Alexa Fernanda Uriostegui Navarro
Climate change has emerged as one of the most important public health challenges of the twenty-first century, profoundly influencing the epidemiology of climate-sensitive diseases and increasing the vulnerability of urban populations worldwide. This review aimed to analyze current scientific evidence regarding the relationship between climate change, climate-sensitive diseases, and the resilience of public health systems, with particular emphasis on urban environments and the Latin American context. A narrative literature review was conducted following the Scientific Method, using publications indexed in PubMed/MEDLINE, Scopus, Web of Science, and official reports issued by international organizations, including the World Health Organization, the Pan American Health Organization, the Intergovernmental Panel on Climate Change, the United Nations, and the World Meteorological Organization. The reviewed evidence demonstrated that rising temperatures, changing precipitation patterns, extreme weather events, environmental degradation, and accelerated urbanization contribute to the increasing burden of vector-borne, respiratory, water- and food-borne, and heat-related diseases. Urban environments were identified as particularly vulnerable because of high population density, socioeconomic inequalities, environmental pollution, and limitations in health infrastructure. The review also highlighted that resilient public health systems incorporating epidemiological surveillance, early warning systems, climate-resilient healthcare infrastructure, technological innovation, and multisectoral governance are essential to strengthen adaptation capacity and reduce climate-related health impacts. Overall, the findings support the integration of climate adaptation into routine public health planning and emphasize the importance of international collaboration, sustainable urban development, and evidence-based policies to protect increasingly urbanized populations under future climate scenarios.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
MQMiguel Horacio Quijano
Miguel Horacio Quijano
BIBenitez Barrios Sosimo Isaac
Benitez Barrios Sosimo Isaac
ALAndres Mauricio Jaimes Lázaro
Andres Mauricio Jaimes Lázaro
Robinson Alexander Morey ContrerasRobinson Alexander Morey Contreras
Robinson Alexander Morey Contreras
LPLuis Felipe Espinal Pérez
Luis Felipe Espinal Pérez
JSJoseph Rodríguez Sánchez
Joseph Rodríguez Sánchez
The vaginal microbiome has emerged as a fundamental determinant of female reproductive health and a promising therapeutic target for the prevention and management of gynecological and obstetric complications. This review aimed to critically analyze the current scientific evidence regarding emerging microbiome-targeted therapeutic approaches, emphasizing their biological mechanisms, clinical effectiveness, therapeutic potential, and future applications in personalized reproductive medicine. A structured narrative review based on the Scientific Method was conducted using publications retrieved from internationally recognized databases, including PubMed, Scopus, Web of Science, ScienceDirect, SpringerLink, Nature Portfolio, and Google Scholar. Recent evidence demonstrates that vaginal dysbiosis is strongly associated with bacterial vaginosis, recurrent vulvovaginal candidiasis, infertility, recurrent urinary tract infections, preterm birth, and other adverse pregnancy outcomes. The analyzed literature indicates that probiotics currently possess the strongest clinical evidence, while live biotherapeutic products, vaginal microbiota transplantation, postbiotics, prebiotics, and advanced vaginal drug delivery systems represent rapidly evolving therapeutic alternatives with considerable potential for restoring microbial homeostasis. These interventions extend beyond pathogen elimination by promoting immune regulation, epithelial barrier integrity, long-term microbial stability, and personalized therapeutic strategies. Although important methodological limitations remain, including heterogeneity among studies and limited long-term clinical data, microbiome-directed therapies are expected to play an increasingly significant role in precision reproductive medicine. Continued multidisciplinary research and high-quality clinical trials will be essential to facilitate their safe and effective integration into routine gynecological and obstetric practice.
1

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
BIBenitez Barrios Sosimo Isaac
Benitez Barrios Sosimo Isaac
MAMelany Patricia Bolagay Apráez
Melany Patricia Bolagay Apráez
Robinson Alexander Morey ContrerasRobinson Alexander Morey Contreras
Robinson Alexander Morey Contreras
MRMiguel Alberto Montañez Romero
Miguel Alberto Montañez Romero
JSJuan José Vergara Serpa
Juan José Vergara Serpa
JEJorge Angel Velasco Espinal
Jorge Angel Velasco Espinal
Stroke remains a major cause of long-term neurological disability worldwide, creating a growing need for rehabilitation strategies capable of promoting functional recovery through intensive, repetitive, task-oriented, and personalized interventions. Digital neurorehabilitation has emerged as a multidisciplinary approach that integrates neuroscience, physical and rehabilitation medicine, neurology, and biomedical engineering through technologies such as virtual reality, robot-assisted rehabilitation, brain-computer interfaces, wearable sensors, artificial intelligence, and telerehabilitation. This review analyzed international scientific evidence regarding the application of these technologies after stroke, with particular attention to their relationship with experience-dependent neuroplasticity, functional outcomes, implementation challenges, and applicability across different healthcare environments, including Latin America. Scientific evidence was identified and critically synthesized from internationally recognized databases, prioritizing randomized controlled trials, systematic reviews, meta-analyses, clinical guidelines, and relevant contemporary studies. The reviewed literature showed that virtual reality and robot-assisted rehabilitation constitute the most extensively investigated technological approaches, with favorable findings particularly in upper-limb motor function, balance, gait, functional mobility, and activities of daily living. Telerehabilitation and wearable technologies provide additional opportunities for extending therapeutic continuity and objective monitoring beyond specialized rehabilitation facilities, while brain-computer interfaces and artificial intelligence represent emerging approaches for neural feedback and personalized rehabilitation. Despite these advances, considerable heterogeneity remains regarding intervention protocols, technological platforms, therapeutic intensity, outcome measures, and patient characteristics. Furthermore, acquisition costs, infrastructure requirements, professional training, accessibility, connectivity, and digital literacy continue to influence implementation, particularly in resource-constrained healthcare systems. Current evidence supports digital technologies as complementary components of multidisciplinary stroke rehabilitation rather than substitutes for conventional therapy. Future research should prioritize standardized protocols, multicenter studies, long-term functional outcomes, cost-effectiveness, equitable accessibility, and greater representation of Latin American populations to advance toward evidence-based precision neurorehabilitation.
1